---  
layout: startup_page  
title: "Paradigm Therapeutics"  
id: "paradigmtherapeutics.com"  
permalink: "/paradigmtherapeuticsparadigmtherapeutics.com06182025/"  
website: "https://www.paradigmtherapeutics.com/"  
funding_round: "Strategic Investment"  
funding_amount: "$12.6M"  
investors: "Eshelman Ventures, LLC"  
about: "Paradigm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies to address critical medical needs in the treatment of rare diseases. Their primary focus is the treatment of Epidermolysis Bullosa (EB). SD-101, Paradigm's leading therapy, is a topical cream for treating skin effects in EB patients, currently having completed Phase II and Phase III clinical trials."  
markets: "Biotech, Pharmaceuticals, Dermatology"  
hq: "Mount Pleasant, South Carolina, United States"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/paradigm-therapeutics-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: ""  

date_display: "18-Jun-2025"  
date: "2025-06-18"

# SEO Optimization  
meta_title: "Paradigm Therapeutics - Strategic Investment Funding ($12.6M)"  
meta_description: "Paradigm Therapeutics, Paradigm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies to address critical medical needs in..."  
meta_keywords: "Paradigm Therapeutics, Biotech, Pharmaceuticals, Dermatology, Strategic Investment funding"  
canonical_url: "https://startup.projectstartups.com/paradigmtherapeuticsparadigmtherapeutics.com06182025/"  
---